Indoor environmental exposures and symptoms. by Hodgson, Michael
Over the last several years it has become
popular to attribute nonspeciﬁc symptoms in
the indoor environment to the complex mix-
ture of volatile organic compounds and par-
tictulate matter, often called a “primordial
soup,” in indoor air in ofﬁces and to individu-
als’ states of mind, implying that there are
neither scientiﬁc explanations for such symp-
toms nor solutions. In the context of the
medically unexplained symptoms discussed in
this monograph, such statements reﬂect wide-
spread attitudes about patients and work-
places. The term “sick building syndrome”
has been used for 20 years without an opera-
tional deﬁnition. The term represents primar-
ily a starting point for conceptual analysis (1).
Attempts to provide alternative names, for
example, problem buildings, building-related
occupant complaint syndrome, abused build-
ing syndrome, and many others, have not met
with success, and the term remains in com-
mon use. Attempts at defining alternatives
reveal two major confusions:
• Is the issue one of feeling sick or appearing
to be dysfunctional or are problems objec-
tively measurable?
• What can we explain when symptoms are
not objectively measurable?
In addition, in the context of other syn-
dromes such as chronic fatigue, ﬁbromyalgia,
and multiple chemical sensitivity, how can
we understand similarities in presentation,
mechanisms of illness, and long-term out-
comes, including disability? 
What do we do about disability related
to such symptoms?
This review is a summary of what we
know of physiology and exposures in indoor
environments and concludes with unan-
swered questions. The central tenet is that
we can explain many symptoms but that
such explanations will not satisfy the ques-
tion driving the investigations, that is, the
degree of disability that patients experience.
A potential nosology of disease for all the
syndrome categories is presented at the end.
Is There a Basis for Feeling
Sick in the Built Environment?
Well-Deﬁned Disease
Data from around the world suggest that
complaints in buildings are ubiquitous,
occurring on all continents where they have
been gathered. Some of these represent dis-
eases related to exposures in the indoor envi-
ronment, which have been documented in
the peer-reviewed literature, with defined
diagnostic criteria. Standard textbooks pre-
sent lists of the diseases and of diagnostic
and linkage criteria. We recognize broad
groups of chemical toxicity, such as from
carbon monoxide, organophosphates, and
thallium; infections, such as tuberculosis,
Legionnaire’s disease, and viral illness; and a
range of allergic and immunologic diseases,
from allergic rhinitis to hypersensitivity
pneumonitis. Although the diseases are
straightforward, often physicians fail to con-
sider them. Recent data suggest, for example,
that hypersensitivity pneumonitis is fre-
quently misdiagnosed. More recent out-
breaks (2–4) suggest that occupants with few
symptoms and only strong complaints of
fatigue and nausea with minimal chest com-
plaints may have evidence of granulomatous
pulmonary disease on biopsy.
Although characterization of those
symptoms and diagnosis of disease are often
straightforward, linkage to an exposure
requires far deeper considerations. For some,
such as asthma or acute hypersensitivity pneu-
monitis, linkage strategies using physiologic
measures are fairly straightforward. Tests are
well deﬁned, widely available, and persuasive
by themselves as a measure of disease. On the
other hand, immunologic testing, although a
valid and widely used approach, is not so
straightforward. Antibodies serve as reason-
able markers of exposure but not of disease
(5), and in many recent outbreaks they have
not even supported linkage with any particu-
lar microorganism. Conversely, since initial
building investigations, evidence shows an
association of symptoms with moisture. In
the course of searching for moisture and
humidifier fever (6) in buildings, Finnegan
et al. (7) found that symptoms were associ-
ated with humidification and ventilation.
Subsequently, cross-sectional studies have
supported an association of higher rates of
symptoms with endotoxin exposure (8) and
with the presence of unwanted moisture in
ventilation systems (9).
The presence of major deficiencies in
building systems, such as unwanted mois-
ture with bioaerosol growth, in parallel with
plausibly related disease usually serves as
adequate evidence to warrant remediation.
Similarly, the development of pesticide
poisoning or headaches in the setting of a
plausible exposure (entrainment of organo-
phosphates or carbon monoxide) with
reasonable biological markers (elevated car-
boxyhemoglobin or depressed but sub-
sequently normalizing cholinesterase levels)
represents adequate evidence of disease.
Some infectious diseases rely on relatively
straightforward, although sometimes expen-
sive, linkage strategies. Identical Legionella
strains identified from patient fluids and
environmental sources with a probable
route, or polymerase chain reaction charac-
terization of tuberculosis, relatively rare
events, are simple. Upper respiratory infec-
tions, on the other hand, a very common
problem, occurring at 1.5- to 2-fold rates in
commercial office buildings with mechani-
cal ventilation, are currently essentially
impossible to link to the workplace.
Some diseases clearly recognized as
building related may cause disability and




The symptoms frequently labeled “sick build-
ing syndrome” result from several different
mechanisms, some better understood than
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others, none of which result in disability from
our current understanding of physiology. In
fact, Jaakola (1) has argued that the lack of an
operational deﬁnition reﬂects the widespread
recognition that the syndrome represents a
theoretical construct for discussion purposes
only. Still, mechanisms to explain these symp-
toms have been identiﬁed, although attribu-
tion of individual symptoms to individual
exposures still remains a problem.
Several sets of data identify multiple
deﬁciencies in virtually all buildings in which
complaints have been identified (10–12).
Few data suggest that such widespread failure
of buildings to meet professional expectations
is associated with symptoms, primarily
because few studies have been designed to
examine this hypothesis, although reviews on
this topic (13) do suggest associations with
building factors in general. In addition, indi-
vidual studies suggest the ability to change
symptoms based on systematic interventions
on moisture content (14,15), particulates
(16,17), or known sources (18). This suggests
that many of these symptoms may in fact
have remediable causes.
Volatile Organic Compounds
Molhave and colleagues in Denmark have
pursued the hypothesis since the early 1980s
that complex mixtures of volatile organic
compounds (VOCs) might be the primary
cause of mucosal irritation, a prominent symp-
tom, and that these agents might in some way
also contribute to headaches, fatigue, and
dizziness (19,20). Chamber studies have con-
firmed in Denmark and the United States
that symptoms increase in humans and ani-
mals after controlled exposures. In addition,
individuals with atopy respond with more
symptoms at lower levels of exposure (21).
Field studies support such relationships.
Sundell and colleagues (22,23) found that
symptoms appeared to be related not only to
ventilation rates but also to “lost” VOCs. The
concentration of VOCs entering the room
was higher than that leaving the room, the
difference being termed “lost VOCs.” As the
VOC concentration difference increased from
air intake to exhaust, symptoms increased.
This decrease likely reﬂects chemical reactions
with reactive agents like ozone that create
more irritating, smaller molecules (see indoor
chemistry discussion, later). Hodgson et al.
(24) suggested that symptoms were associated
with increasing concentrations of VOCs as
measured with a screening device that
responds to more reactive VOCs (photoion-
ization detector). Ten Brinke et al. (25) iden-
tified relationships between symptoms and
clusters of VOCs by likely emission sources,
suggesting that individual building compo-
nents, such as carpeting or latex paint
emissions, contributed to symptoms.
Mucosal Irritation
More important, such symptoms, commonly
attributed to the common chemical sense,
appear to follow predictable dose–response
relationships with increasing concentrations
of complex mixtures of VOCs. Abraham
(26) used the irritation thresholds derived in
these investigations to develop a quantita-
tive structure–activity relationship that
allows the prediction of irritation based on
the physical characteristics of the molecules.
The equation is based on the equations
developed by Meyer and colleagues in the
early part of this century for anesthetic
agents, and more recent systematic attempts
using complex statistical modeling to under-
stand physicochemical properties. These
characteristics explained 98% of the vari-
ance in models to explain irritation.
Subsequently, Alarie et al. (27) demon-
strated that some “reactive” species trigger
symptoms that do not follow this predictable
pattern and therefore that irritation from
reactive species must be caused by a different
mechanism. Weschler and Shields (28) and
Wilkins et al. (29) have examined the rela-
tionships of reactive species with such rela-
tively nonreactive agents and shown that
“indoor chemistry” produces far more irritat-
ing substances at a ratio of 2:1 compared
with the initial nonirritating agent. Indoor
chemistry in this context refers to the reac-
tions of compounds such as ozone and nitro-
gen oxides with relatively inert VOCs in a
fashion that oxidizes them and produces two
more irritating for each single previously
inert molecule. This effect has been demon-
strated for carpet emissions, latex paint off-
gassing, and other common ofﬁce pollutants.
Finally, markers of exposure have been
identified. Symptomatic individuals appear
to have tear ﬁlm breakup time, conjunctival
staining with ﬂuorescein dye, and erythema
on photography that appear different from
asymptomatic building occupants (30–32).
Tsubota (33) has reviewed the physiology of
tear ﬁlm production and suggests two mech-
anisms by which underlying susceptibility
might increase eye complaints. First, both
decreased basal and reﬂex stimulation lead to
dry eye complaints. In addition, decreased
Meibomian gland lipid secretion will allow
more rapid evaporation of tear fluid in the
presence of enlarged exposed ocular surface
during computer screen work (34). The
overlaps of the two groups are large enough
to preclude use of these tests in the clinical
discrimination of symptom causation.
The recognition of excess symptoms in
the late 1970s led to chamber studies identi-
fying mechanisms in people and animals,
dose–response relationships in controlled
exposure studies, markers in humans sup-
porting some “real effect,” and ﬁeld studies
identifying the relationship in unselected
populations. VOCs clearly represent at least
one cause of mucosal irritation in indoor
environments.
Headaches
Headaches represent the single most common
symptom in almost all indoor environmental
studies (35,36). Although rare outbreaks of
carbon monoxide poisoning occur, most
headaches represent events without clear char-
acterization in the ofﬁce environment. These
have generally not been classiﬁed into stan-
dard categories (37) by the most widely
accepted and used nosology. Such standard
categories reﬂect the current state of knowl-
edge on mechanisms for some forms of
headache, such as migraine, and allow identi-
fication of other forms without as yet
explained physiology, such as tension-type
headache. Such headaches are no less impor-
tant given the productivity implications (38)
and the potential for effective intervention
and disability reduction in the ofﬁce environ-
ment (39). Although higher symptom rates
appear associated with speciﬁc exposures, such
as VOCs, and with building factors, this may
explain triggering of symptoms but not neces-
sarily initial induction of conditions such as
the tendency toward migraines.
Thermal Discomfort
Since the early part of this century, engineers
have recognized that thermal discomfort is a
major contributor to indoor environmental
complaints. Flugge [reviewed in Jansen (40)]
demonstrated that odor perception and heat
sensation were the main reasons for ventilat-
ing occupied space. Subsequent empiric
work has confirmed that the thermal com-
fort envelope does not provide an adequate
margin of comfort when other modalities of
exposure approach their own acceptability
boundaries. Exceedance beyond the thermal
comfort envelope is associated with increases
in symptoms not commonly attributed to
that domain, such as headaches, mucosal
irritation, and fatigue.
Complaints of being too hot or too cold
are often associated with headaches, fatigue,
and mucosal irritation. The thermal comfort
envelope in offices is controlled by the
Standard 55 Thermal Conditions for
Human Occupancy from the American
Society of Heating, Refrigerating and Air
Conditioning Engineers (41). Maintaining
thermal parameters within the confines of
the comfort envelope under ideal conditions
satisfied approximately 80% of the popula-
tion, although in practice usually far greater
proportions are uncomfortable. The reasons
are manifold. Clothing often provides more
or less thermal “protection” than assumed
under ideal conditions. Ofﬁce furniture has
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changed, with newer chairs often providing
more thermal resistance and creating a hotter
environment than calculated in the standard.
Increasing numbers of electronic devices
provide greater heat loads in the ofﬁce than
those for which many buildings were
designed. Finally, current mathematical
models of thermal comfort, on which cur-
rent standards are based, fail to include
dynamic aspects of work (recent exercise and
heat loading), aging, and other critical issues.
In any case measurement of temperature and
relative humidity often shows poor control,
suggesting additional environmental contri-
butions to symptoms of headaches, fatigue,
and mucosal irritation.
Symptoms without Explained
Physiology but with Objective
Markers
Increasingly, outbreaks present with multiple
forms of disease, where various combina-
tions of asthma, hypersensitivity pneumoni-
tis, and interstitial pneumonitis appear
together (3,42,43). In parallel, excess chest
symptoms such as wheezing, chest tightness,
and coughing (9) suggest that symptoms
consistent with asthma are not infrequent,
associated with moisture. Well-documented
cases of disease appear to be accompanied
by less clearly defined excess rates of upper
airways symptoms, without clearly defined
mechanisms (42,44).
Still, these symptoms cannot be easily
explained based on current physiologic or
immunologic knowledge. If they represent
“real symptoms,” that is, have a cause in the
external environment, they too must have
some objective markers and eventually show
some relationship with external exposures.
So, are they accompanied by markers that
indicate something we do not yet know how
to explain is going on?
There is, meanwhile, clear evidence from
nasal lavage studies that bioaerosol exposure
is associated with some immunologic mark-
ers that are not present in individuals with-
out exposure or symptoms (45,46). As in the
past, the lack of an explanation for symp-
toms in individuals may reflect our lack of
research rather than the absence of some
cause and effect.
Similarly, despite the fundamental validity
of dose–response relationships, clear evi-
dence of markers for individual susceptibility
separate normal from more sensitive groups.
For example, chamber data identify higher
levels of symptoms in atopic individuals
exposed to the same levels of complex mix-
tures of VOCs (16,47,48). Atopic individu-
als respond with a larger decrease in nasal
resistance to a deﬁned irritant challenge than
do nonatopics (49). Higher-than-average
symptoms after application of dilute lactic
acid to the skin are associated with more
dermal complaints in the office (50).
Additional markers that differentiate groups
of individuals with more from those with
fewer symptoms include nasal hyperreactiv-
ity (51,52) and more rapid tear film
breakup time (30,31). Still, the underlying
assumption remains that these markers
reﬂect either underlying mechanisms or sus-
ceptibility and simply shift the dose–
response curve in some predictable fashion.
Odors
Similarly, odors feature prominently in
anhedonic responses in the indoor environ-
ment and are sometimes considered an inte-
gral part of the sick building syndrome
construct. Nevertheless, models to explain
odorant properties are substantially less well
developed. Boswell et al. (12) systematically
examined the problem of potential indoor
odor sources using a well-deﬁned protocol in
only one study and found that almost 80%
of transient odor complaints had identiﬁable
and remediable causes. Odors associated
with moisture and bioaerosol exposure are
common and best considered in the context
of disease with physiologic indicators. Some
VOCs have distinct odor recognition charac-
teristics, but those are then best considered
part of the mucosal irritant syndromes.
Odor recognition thresholds are usually sev-
eral orders of magnitude below the irritant
thresholds (53).
The mechanism for odor recognition is
well studied. Although there are attempts at
developing structure–activity relationship
models analogous to that of Abraham (26),
such models show much poorer ﬁt. In addi-
tion, “odors” do not present a clinical out-
come suggesting a well-deﬁned syndrome.
Symptoms, Exposures, and
Disability
There is evidence to document and even
explain many symptoms at the levels com-
monly encountered in indoor spaces. Because
these symptoms represent well-deﬁned physi-
ologic mechanisms, the label “sick building
syndrome” should not be considered synony-
mous with “unexplained.” Most symptoms
in the built environment, however, do not
represent disease as recognized by clinicians.
For some exposures such as bioaerosols, con-
ditions may be evaluated using very tradi-
tional tests for well-deﬁned conditions such
as asthma or hypersensitivity pneumonitis.
There, at least, objective evidence of disease
makes subjective perceptions of illness under-
standable. Although low levels of VOCs may
cause symptoms, including mucosal irritation
and headaches, no data explain how such
symptoms may generate disability at such
low levels. The degree of subjective symptom
intensity often correlates only poorly with the
degree of impairment as defined by organ
dysfunction, a well-known problem in
disability evaluations.
Some authors have argued that sick
building syndrome has similarities to chronic
fatigue syndrome, fibromyalgia, and multi-
ple chemical sensitivity. Strikingly, although
epidemiologic and clinical case definitions
have been developed for these three condi-
tions, it remains unclear whether all subjects
meeting those definitions experience the
same illness. For example, multiple chemical
sensitivity reflects, in the minds of some
investigators, respectively, irritation in
underlying chronic sinusitis, conditioned
psychological responses to external stimuli,
misinterpretation of a normal sensation, and
an obsessive-compulsive personality disorder.
Case deﬁnitions do not imply cause (54,55).
No case deﬁnitions even exist for sick build-
ing syndrome. Questionnaire-based studies
of buildings always include some aspect of
prompt symptom resolution with leaving the
work environment, implying resolution of
the syndrome. This distinguishes the syn-
drome quite dramatically from common
descriptions of multiple chemical sensitivity,
where patients often describe longer-term
symptoms with “dis-ability” lasting days and
weeks after an exposure. 
It is difficult to consider occupant
discomfort and symptoms in the built envi-
ronment without acknowledging that all
discomfort and disease have a psychologic
component. It is clear that symptoms are
strongly associated with psychological fac-
tors [reviewed in (13,56)]. Specific signs
such as facial erythema are associated with
traditional biologic markers of stress (57).
As important, work stress appears consis-
tently associated with symptoms (13). This
may simply reflect our much more robust
ability to characterize work stress and our
lack of knowledge about specific exposure
assessment techniques than a true stronger
relationship. Although work stress is associ-
ated with symptoms, it is a theoretical con-
struct that reﬂects beliefs and interpretations
of the discussant. It does not imply a spe-
cific psychiatric diagnosis nor does it really
address the causes of discomfort, exaggera-
tion of symptoms, and distortion of the
dose–response relationships.
Pain represents a predictable subjective
response to stimuli and has its own body of
scientiﬁc literature. Elsewhere in this mono-
graph, authors discuss the relationships
between the objective stimuli and two kinds
of subjective responses, the physiologic sensa-
tion and the experience of the associated pain
and discomfort. These may diverge in a pre-
dictable fashion, as has been shown for mul-
tiple chemical sensitivity and ﬁbromyalgia.
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must first attempt to define what we see,
classify phenomena into some set of recog-
nizable conditions that allow us to formulate
treatment plans, and establish criteria that let
us postulate hypotheses for further testing.
One example of such nosologic attempts and
where they led is the New York Heart
Association classification of heart disease
(58). Such an approach worked well from
the 1950s through the 1970s in the attempt
to communicate about heart disease, to agree
on standards of treatment, and to guide
research questions. Based on the descriptions
above, and elsewhere in this monograph,
questions about each of the syndromes may
be classified by a specific set of tools. Such
systematic data gathering about the various
syndromes may complement the research
efforts of individual groups and provide
understanding of the shared characteristics
of these syndromes. International compar-
isons suggest that “disability” can only be
understood in a social context, that is, when
considering not just subjective experience
but also the social and legislative infrastruc-
ture in which individuals live. An interna-
tional study of disability has attempted to
describe the social and legislative infrastruc-
ture surrounding the concept of disability
across countries (59). Recently, the World
Health Organization has released its updated
classiﬁcation on functioning, disability, and
health (60). The grouping now considers
four major classifications (body functions,
body structures, activity and participation,
and environmental factors). Such systematic
attempts at classification have not been
undertaken for the understanding of unex-
plained symptoms or, more broadly of dis-
ability, symptoms, medical health, and the
physiologic implications.
How can researchers then look beyond
physiology to understand? 
One possible set of classiﬁcation criteria
to be used for the next years might include
those presented in Table 1. For obvious rea-
sons, the presenting case deﬁnition, as agreed
upon elsewhere, should be the starting point.
This requires agreement on case deﬁnitions
for multiple chemical sensitivities,
fibromyalgia, and so on. Still, additional
symptoms of interest not typically associated
with that syndrome must be queried in a sys-
tematic fashion, best using questionnaires.
Otherwise, overlaps cannot be determined.
Because of the differences in physiologic
responses to deﬁned stimuli, such as pressure
(thumbscrews) in fibromyalgia or mucosal
irritants (chamber studies) in multiple
chemical sensitivity, physiologic characteris-
tics must be included. Finally, among the
most dramatic unexplained characteristics
are the differences in disability. Traditional
approaches to measurement, such as perfor-
mance or disability scales, appear essential.
As important, personality style and disabil-
ity perceptions remain controversial topics.
The subjective experience of “disability” can
only be understood by examining that expe-
rience. Nevertheless, the scientiﬁc literature
on this topic appears to be sparse based on
literature searches.
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